Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA)

Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA)

Abstract Background Anti-tumor necrosis factor (TNF) drugs have improved the prognosis for juvenile idiopathic arthritis (JIA) significantly. However, evidence for individual treatment decisions based on serum anti-TNF drug levels and the presence of anti-drug antibodies (ADAbs) in children is scarc...

Full description

Bibliographic Details
Main Authors: A. Nassar-Sheikh Rashid, D. Schonenberg-Meinema, S. C. Bergkamp, S. Bakhlakh, A. de Vries, T. Rispens, T. W. Kuijpers, G. Wolbink, J. M. van den Berg
Format: Article
Language:English
Published: BMC 2021-04-01
Series:Pediatric Rheumatology Online Journal
Subjects:
Biologics
Anti-TNF drug trough levels
Anti-drug antibodies
Children
Juvenile idiopathic arthritis (JIA)
Online Access:https://doi.org/10.1186/s12969-021-00545-x

Internet

https://doi.org/10.1186/s12969-021-00545-x

Similar Items